|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Departments of Pediatrics (IMvB, LA, DO-vE, and HJB), Endocrinology (MdH), Epidemiology and Biostatistics (MdH), Obstetrics and Gynecology (CMGT), and Chemical Endocrinology (CMGT), Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background: Vitamin status, methylenentetrahydrofolate reductase (MTHFR) genotype, age, sex, and lifestyle factors are all predictors of total homocysteine (tHcy) concentrations in adults. Limited data are available about the influence of these factors on tHcy in children.
Objective: The objective was to describe tHcy and its predictors in Dutch children.
Design: A sample of 234 white children aged 019 y was analyzed cross-sectionally.
Results: The geometric mean tHcy concentrations were 5.1 (95% CI: 4.6, 5.6), 4.6 (4.2, 5.1), 6.2 (5.6, 6.9), 7.3 (6.7, 8.0), and 8.7 (7.9, 9.6) µmol/L in the 01, 25, 610, 1114, and 1519 y groups, respectively. Plasma folate and vitamin B-12 concentrations decreased markedly with age. The inverse association between tHcy and plasma folate seen at all ages was stronger than that between tHcy and plasma vitamin B-12. A negative association of plasma folate with tHcy was confined to folate concentrations <20 nmol/L. Homozygosity for the MTHFR 677C
T polymorphism was identified in 8.2% of the children. The homocysteine concentration did not differ significantly between the MTHFR genotypes.
Conclusions: This study provided age-specific data regarding tHcy concentrations and their predictors in the whole range of childhood. The tHcy concentration increased as a function of age in both sexes. Plasma folate was a concentration-dependent predictor of tHcy. The MTHFR 677C
T polymorphism played a minor role in determining tHcy concentrations in children.
Key Words: Children creatinine folate total homocysteine methylenetetrahydrofolate reductase MTHFR vitamin B-12
This article has been cited by other articles:
![]() |
K. J. Adebayo, E. F. Madu, and V. C. Adebayo-Kay Serum Total Homocysteine Concentrations in Children and Adolescents in Jos, Nigeria J Trop Pediatr, February 23, 2008; (2008) fmn006v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sharp, Z. Miedzybrodzka, A. H. Cardy, J. Inglis, L. Madrigal, S. Barker, D. Chesney, C. Clark, and N. Maffulli The C677T Polymorphism in the Methylenetetrahydrofolate Reductase Gene (MTHFR), Maternal Use of Folic Acid Supplements, and Risk of Isolated Clubfoot: A Case-Parent-Triad Analysis Am. J. Epidemiol., November 1, 2006; 164(9): 852 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. van Beynum, L. Kapusta, M. den Heijer, S. H.H.M. Vermeulen, M. Kouwenberg, O. Daniels, and H. J. Blom Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation Eur. Heart J., April 2, 2006; 27(8): 981 - 987. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |